EUVIMEDEUVIMED entdecken
Open Access

Pituitary-derived Follicle stimulating hormone has greater follicle-stimulating bioactivity than recombinant Follicle stimulating hormone possibly due to glycoform variants

Zihui Wu, Nan Sun, Jiabin Tang, Linghua Xu, Xinrui Zhou, Menglei Jiang, Jiarui Cheng, Xuedan Zhu, Miaoyu Liu, Liguo Yang, John S Davis, Guohua Hua iD

Biology of Reproduction · 2025

DOI: 10.1093/biolre/ioaf173 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biology of Reproduction, 2025. Verfasst von Zihui Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Technology, Key Laboratory of Agriculture Animal Genetics, Breeding and Reproduction, Ministry of Education, Huazhong A…. Hauptthemen laut MEDLINE: Ovarian Follicle, Follicle Stimulating Hormone, Pituitary Gland. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NIA NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Follicle-stimulating hormone is the primary gonadotropin regulating ovarian follicular development and is widely utilized in assisted reproduction. Our previous research indicated that different glycoforms of the follicle-stimulating hormone Beta-subunit influence follicular development in vivo, but their specific roles across various folliculogenesis stages remained unclear. In this study, we compared two commercial follicle-stimulating hormone preparations: pituitary-derived follicle-stimulating hormone, which contains both fully and hypo- glycosylated Beta-subunit forms, and recombination follicle-stimulating hormone, predominantly consisting of fully glycosylated forms. Using an in vitro follicular culture model, we observed that pituitary-derived follicle-stimulating hormone was more effective than recombination follicle-stimulating hormone in stimulating follicular growth and promoting antrum formation in preantral follicles. Pituitary-derived follicle-stimulating hormone also rescued insufficient preantral follicle growth and antrum formation caused by recombination follicle-stimulating hormone. Besides, pituitary-derived follicle-stimulating hormone more efficiently drove small antral follicle growth than recombination follicle-stimulating hormone. Additionally, pituitary-derived follicle-stimulating hormone significantly increased the granulosa cells proliferation and effectively inhibited apoptosis, thereby protecting growing follicles from atresia. Pituitary-derived follicle-stimulating hormone also induced higher steroidogenesis than recombination follicle-stimulating hormone. Mechanistically, pituitary-derived follicle-stimulating hormone activated key downstream signaling including protein kinase A/cAMP-response element binding protein, mitogen-activated protein kinase/extracellular signal-regulated kinase, and phosphatidylinositol 3-kinase/AKT more efficiently than recombination follicle-stimulating hormone. Importantly, pre-treating antral follicles with pituitary-derived follicle-stimulating hormone significantly improved ovulation rate following human chorionic gonadotropin administration. This was linked to a rapid upregulation of luteinizing hormone/choriogonadotropin receptor expression and enhanced mitogen-activated protein kinase/extracellular signal-regulated kinase signaling activity. Collectively, our data support that pituitary-derived follicle-stimulating hormone, with its mixture of fully and hypo-glycosylated forms, has greater bioactivity in promoting preantral–antral transition, antral follicle growth, and ovulation compared to recombination follicle-stimulating hormone, which mainly consists of fully glycosylated follicle-stimulating hormone. Application of mixed glycoforms or hypo-glycosylated follicle-stimulating hormone may improve the outcomes in assisted reproduction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian FollicleFollicle Stimulating HormonePituitary GlandFemaleAnimalsRecombinant ProteinsMiceGlycosylationGranulosa Cells

Stichwörter der Autor:innen

FSHantral folliclesfollicular developmentglycoformovulationpre-antral follicles

Substanzen

Follicle Stimulating HormoneRecombinant Proteins

Autor:innen und Institutionen

  • College of Animal Science and Technology, Key Laboratory of Agriculture Animal Genetics, Breeding and Reproduction, Ministry of Education, Huazhong Agriculture University, Wuhan, Hubei, P.R. China.
  • Frontiers Science Center for Animal Breeding and Sustainable Production, Huazhong Agricultural University, Wuhan, Hubei, P.R. China.
  • Hubei Hongshan Laboratory, Wuhan, Hubei, P.R. China.
  • National Center for International Research on Animal Genetics, Breeding and Reproduction, Wuhan, Hubei, P.R. China.
  • Shenzhen Branch, Guangdong Laboratory for Lingnan Modern Agriculture, Genome Analysis Laboratory of the Ministry of Agriculture, Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences, She…
  • Olson Center for Women's Health, Department of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha, Nebraska, USA.

ORCID-Profile: Guohua Hua

Förderung

  • BLRD VA
  • NIA NIH HHS
  • NICHD NIH HHS

Zitieren

APA

Wu, Z., Sun, N., Tang, J., Xu, L., Zhou, X., Jiang, M., Cheng, J., Zhu, X., Liu, M., Yang, L., Davis, J. S., & Hua, G. (2025). Pituitary-derived Follicle stimulating hormone has greater follicle-stimulating bioactivity than recombinant Follicle stimulating hormone possibly due to glycoform variants. Biology of Reproduction. https://doi.org/10.1093/biolre/ioaf173

Vancouver

Wu Z, Sun N, Tang J, Xu L, Zhou X, Jiang M, et al. Pituitary-derived Follicle stimulating hormone has greater follicle-stimulating bioactivity than recombinant Follicle stimulating hormone possibly due to glycoform variants. Biology of Reproduction. 2025. doi:10.1093/biolre/ioaf173

BibTeX
@article{Wu2025,
  author = {Wu, Zihui and Sun, Nan and Tang, Jiabin and Xu, Linghua and Zhou, Xinrui and Jiang, Menglei and Cheng, Jiarui and Zhu, Xuedan and Liu, Miaoyu and Yang, Liguo and Davis, John S and Hua, Guohua},
  title = {Pituitary-derived Follicle stimulating hormone has greater follicle-stimulating bioactivity than recombinant Follicle stimulating hormone possibly due to glycoform variants},
  journal = {Biology of Reproduction},
  year = {2025},
  doi = {10.1093/biolre/ioaf173}
}
Kostenlos starten →